A detailed history of Horizon Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Horizon Wealth Management, LLC holds 491 shares of REGN stock, worth $350,804. This represents 0.1% of its overall portfolio holdings.

Number of Shares
491
Previous 491 -0.0%
Holding current value
$350,804
Previous $516,000 -0.0%
% of portfolio
0.1%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$883.2 - $1071.19 $13,248 - $16,067
-15 Reduced 2.96%
491 $516,000
Q1 2024

Apr 18, 2024

BUY
$902.69 - $993.35 $13,540 - $14,900
15 Added 3.05%
506 $487,000
Q4 2023

Jan 22, 2024

BUY
$775.18 - $881.7 $3,875 - $4,408
5 Added 1.03%
491 $431,000
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $9,526 - $11,577
-14 Reduced 2.8%
486 $399,000
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $271,740 - $335,485
500 New
500 $316,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Horizon Wealth Management, LLC Portfolio

Follow Horizon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Wealth Management, LLC with notifications on news.